KORU Medical Systems (KRMD) Stock Price, News & Analysis

Company Overview

KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.

Key Stats

• Today's Range: $2.18 to $2.44
• 50-Day Range: $2.06 to $4.75
• 52-Week Range: $1.86 to $5.05
• Volume: 82,534 shs
• Average Volume: 139,941 shs
• Market Capitalization: $102.94 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $4.70
• Consensus Rating: Buy

KORU Medical Systems Stock Analysis - MarketRank™

KORU Medical Systems scored higher than 57% of companies evaluated by MarketBeat, and ranked 523rd out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

KORU Medical Systems has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

KORU Medical Systems has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for KORU Medical Systems are expected to grow in the coming year, from ($0.13) to ($0.08) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of KORU Medical Systems is -8.96, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of KORU Medical Systems is -8.96, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

KORU Medical Systems has a P/B Ratio of 4.98. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.19% of the float of KORU Medical Systems has been sold short.

Short Interest Ratio / Days to Cover

KORU Medical Systems has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in KORU Medical Systems has recently decreased by 4.64%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

KORU Medical Systems does not currently pay a dividend.

Dividend Growth

KORU Medical Systems does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

1.19% of the float of KORU Medical Systems has been sold short.

Short Interest Ratio / Days to Cover

KORU Medical Systems has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in KORU Medical Systems has recently decreased by 4.64%, indicating that investor sentiment is improving.

News and Social Media

• Score: N/A
• News Sentiment: N/A

Company Ownership

• Score: 2.5 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, KORU Medical Systems insiders have not sold or bought any company stock.

Percentage Held by Insiders

20.60% of the stock of KORU Medical Systems is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

58.60% of the stock of KORU Medical Systems is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

KRMD Stock Analysis - Frequently Asked Questions

How have KRMD shares performed this year?

KORU Medical Systems' stock was trading at $3.85 at the beginning of the year. Since then, KRMD shares have decreased by 41.8% and is now trading at $2.24.
View the best growth stocks for 2025 here.

How were KORU Medical Systems' earnings last quarter?

KORU Medical Systems, Inc. (NASDAQ:KRMD) issued its quarterly earnings results on Wednesday, August, 7th. The company reported ($0.02) earnings per share for the quarter, beating analysts' consensus estimates of ($0.04) by $0.02. The company had revenue of $8.43 million for the quarter, compared to the consensus estimate of $7.52 million. KORU Medical Systems had a negative net margin of 37.42% and a negative trailing twelve-month return on equity of 24.60%.
Read the conference call transcript.

How do I buy shares of KORU Medical Systems?

Shares of KRMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of KORU Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some other companies that KORU Medical Systems investors own include Waste Connections (WCN), American Water Works (AWK), The RMR Group (RMR), AUO (AUOTY), DiamondRock Hospitality (DRH), iShares Micro-Cap ETF (IWC) and Triple Flag Precious Metals (TFPM).

Company Calendar

• Last Earnings: 8/07/2024
• Today: 4/21/2025
• Next Earnings (Estimated): 5/07/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:KRMD
• CIK: 704440
• Web: www.korumedical.com
• Phone: (845) 469-2042
• Fax: 845-469-5518
• Employees: 80
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $4.70
• High Stock Price Target: $6.00
• Low Stock Price Target: $4.00
• Potential Upside/Downside: +109.8%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 5 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($0.12)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-13,740,000.00
• Net Margins: -37.42%
• Pretax Margin: -20.40%
• Return on Equity: -24.60%
• Return on Assets: -16.87%

Debt

• Debt-to-Equity Ratio: 0.01
• Current Ratio: 2.99
• Quick Ratio: 2.37

Sales & Book Value

• Annual Sales: $33.65 million
• Price / Sales: 3.06
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.45 per share
• Price / Book: 4.98

Miscellaneous

• Outstanding Shares: 45,957,000
• Free Float: 34,103,000
• Market Cap: $102.94 million
• Optionable: Optionable
• Beta: 0.87